Should we be worried about pharma’s supply chain?
World of DTC Marketing
APRIL 12, 2021
We need a 21st-century approach that puts patient safety first. The US Food and Drug Administration (FDA) believes the adulteration of heparin was an economically motivated act—a clear breach of the US pharmaceutical supply chain. In other words, money over safety. Up to 90% of drugs now sold in the US and UK are generic.
187 
Let's personalize your content